Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529513 · ClinicalTrials.gov registry record
Medibio DDA Confirmatory Performance Study
A clinical trial, sponsored by Medibio Limited.
- Completed
- Registry status
- 234
- Enrollment target
NCT03529513 is a clinical trial that has completed, run by Medibio Limited. The registered enrollment target is 234 participants.
The verdict
NCT03529513 has completed, sponsored by Medibio Limited.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This study will determine whether the Medibio Depression Diagnostic Aid exceeds minimally acceptable thresholds for sensitivity and sensitivity in cases with a current depression episode and non-depressed controls.
Interventions
- DIAGNOSTIC_TEST Medibio Depression Diagnostic Aid
- DIAGNOSTIC_TEST Mini International Neuropsychiatric Interview
- DIAGNOSTIC_TEST Hamilton Rating Scale for Depression - 17 Item
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2017-08-18 |
| Est. Completion | 2018-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03529513
The ClinicalTrials.gov registry entry for NCT03529513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medibio Limited, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medibio Depression Diagnostic Aid is the first listed.
NCT03529513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03529513 about?
NCT03529513 is a clinical study titled "Medibio DDA Confirmatory Performance Study". This study will determine whether the Medibio Depression Diagnostic Aid exceeds minimally acceptable thresholds for sensitivity and sensitivity in cases with a current depression episode and non-depressed controls.
What is the current status of trial NCT03529513?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2017-08-18. Estimated completion is 2018-05-04.
What interventions are being tested in trial NCT03529513?
The interventions under investigation include: Medibio Depression Diagnostic Aid (DIAGNOSTIC_TEST), Mini International Neuropsychiatric Interview (DIAGNOSTIC_TEST), Hamilton Rating Scale for Depression - 17 Item (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03529513?
This trial is sponsored by Medibio Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.